期刊文献+

中性粒细胞相关载脂蛋白表达与胃癌进展、转移及预后的关系 被引量:4

The Correlation of NGAL and Clinicopathologic Progress, Metastasis and Prognosis in Gastric Carcinoma
下载PDF
导出
摘要 目的:探讨中性粒细胞相关载脂蛋白(NGAL)在胃癌组织中的表达及与胃癌进展、转移及预后的关系。方法:应用免疫组化法检测NGAL在102例胃癌、32例正常胃组织中的表达,分析其与胃癌临床病理特征及预后的关系。结果:NGAL在胃癌组织中的阳性表达率为56.9%,明显高于在正常胃组织中的21.9%(χ2=11.938,P<0.01),不同胃癌组织学分型患者NGAL阳性表达差异有统计学意义(χ2=10.180,P<0.05),胃癌患者NGAL表达与浆膜侵犯、TNM分期、淋巴结转移以及T分期呈正相关(rs分别为0.307、0.211、0.220、0.201,P<0.05或P<0.01)。NGAL表达阳性组和阴性组5年累积生存率分别为24.3%和43.7%,差异有统计学意义(P=0.018)。结论:NGAL在胃癌中表达上调,与胃癌进展和淋巴结转移显著相关,提示预后不良,可作为评价胃癌预后新的生物学指标。 Objective: To investigate the expression of neutrophil gelatinase-associated lipocalin (NGAL),and the correlation of NGAL with clinicopathologic progression, metastasis and prognosis in gastric carcinoma. Methods:The expression of NGAL was observed in 102 gastric carcinoma tissues and 32 normal gastric tissues by immunohistochemistry. The correlation of NGAL expression with clinicopathologic parameters and metastasis was analyzed. Results:The positive rate of NGAL expression was 56.9% in gastric carcinoma, which was significantly higher than that in normal gastric tissue (21.9% , χ2 = 11.938, P 0.01). The expression of NGAL was significantly different in patients with different histological types ( χ2 = 10.180, P 0.05). The expression of NGAL was observed to correlate positively with serosal invasion, TNM stage, lymph node status and T stage (rs = 0.307, 0.211, 0.220 and 0.201, P 0.01 or P 0.05). The five-year cumulative survival rates were 24.3% and 43.7% in the positive and negative NGAL expression groups. Kaplan-Meier curves showed a significant difference (P = 0.018). Conclusion: NGAL expression was up-regulated in gastric carcinoma, which was significantly correlated with tumor progression and lymphatic metastasis. The expression of NGAL might be a novel molecular marker to predicate the prognosis of gastric carcinoma.
出处 《天津医药》 CAS 北大核心 2010年第11期933-935,共3页 Tianjin Medical Journal
基金 浙江省自然科学基金资助项目(项目编号:Y207799)
关键词 中性白细胞 载脂蛋白类 胃肿瘤 淋巴转移 预后 免疫组织化学 neutrophils apolipoproteins stomach neoplasms carcinoma lymphatic metastasis prognosis immunohistochemistry
  • 相关文献

参考文献10

  • 1Kjeldsen L, Johnsen AH, Sengelov H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase [J]. J Biol Chem, 1993, 268 (14):10425-10432.
  • 2Furutani M, Afii S, Mizumoto M, et al. Identification of a neutrophil gelatinase-associated lipocalin mRNA in human pancreatic cancers using a modified signal sequence trap method [J]. Cancer Lett, 1998, 122(1-2):209-214.
  • 3Zhang H, Xu L, Xiao D, et al. Upregulation of neutrophil gelatinase- associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion [J]. J Clin Pathol, 2007, 60(5):555-561.
  • 4Lim R, Ahmed N, Borregaard N, et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition [J].IntJCancer, 2007, 120(11): 2426-2434.
  • 5Bauer M, Eickhoff JC, Gould MN, et al. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer [J]. Breast Cancer Res Treat, 2008, 128(3): 389 -397.
  • 6Yah L, Borregaard N, Kjeldsen L, et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL [J]. J Biol Chem, 2001, 276(40):37258-37265.
  • 7张娜,郑海燕,杜华欣,董淑惠,王兴芬,潘彦珞.VEGF-C、NF-κBp65和COX-2与胃癌淋巴结转移的关系[J].天津医药,2009,37(6):459-461. 被引量:8
  • 8Fernandez CA, Yan L, Louis G, et al. The matrix metalloproteinase- 9/neutrophil gelatinase-associated lipocatin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients [J]. Clin Cancer Res, 2005, 11(15):5390-5395.
  • 9Yang J, Goetz D, Li JY, et al. An iron delivery pathway mediated by a lipocalin [J]. Mol Cell, 2002, 10(5):1045-1056.
  • 10Kubben FJ, Sier CF, Hawinkels LJ, et al. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer[J]. Eur J Cancer, 2007,43 ( 12): 1869-1876.

二级参考文献6

共引文献7

同被引文献71

  • 1Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA Cancer J Clin,2015 ,65(2) :87 -108.
  • 2Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer inci- dence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 [ J]. Int J Cancer, 2015, 136(5) :E359 - E386.
  • 3Tabuchi T, Ubukata H, Sato S, et al. Granulocytapheresis as a possible cancer treatment [ J]. Anticancer Res, 1995, 15(3) :985 -990.
  • 4Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? [J]. Lancet,2001,357 (9255) :539 - 545.
  • 5Balkwill F, Charles KA, Mantovani A. Smoldering and po- larized inflammation in the initiation and promotion of ma- lignant disease[J]. Cancer Ce11,2005,7(3) :211 -217.
  • 6Coussens LM, Werb Z. Inflammation and cancer [ J ]. Na- ture,2002,420 (6917 ) : 860 - 867.
  • 7Karin M. Nuclear factor-kappaB in cancer development and progression [ J ]. Nature,2006,441 (792) :431 - 436.
  • 8Mantovani A, Allavena P, Siea A, et al. Cancer-related in- flammation [ J 1. Nature,2008,454 ( 7203 ) :436 - 44.
  • 9Kobayashi H, Gonda T, Uetake H, et al. JTE-522, a selec- tive COX-2 inhibitor,interferes with the growth of lung me- tastases from colorectal cancer in rats due to inhibition of neovascularization, a vascular cast model study [ J]. Int J Cancer. 2004.112 ( 6 ) : 920 - 926.
  • 10Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of color- ectal cancer in relation to the expression of COX-2 [ J]. N Engl J Med,2007,356(21) :2131 -2142.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部